Balancing the Benefits and Harms of Oral Anticoagulation in Chronic Kidney Disease: What Does Available Evidence Tell Us?

Ann Intern Med. 2019 Aug 6;171(3):214-215. doi: 10.7326/M19-1504. Epub 2019 Jul 16.

Authors

Ainslie Hildebrand¹, Christine Ribic², Deborah Zimmerman³

Affiliations

¹ University of Alberta, Edmonton, Alberta, Canada (A.H.).
² McMaster University, Hamilton, Ontario, Canada (C.R.).
³ University of Ottawa, Ottawa, Ontario, Canada (D.Z.).

PMID: 31307054
DOI: 10.7326/M19-1504

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants*
Humans
Renal Insufficiency, Chronic*
Warfarin

Substances

Anticoagulants
Warfarin